...
首页> 外文期刊>BioMed research international >Preparation, Physicochemical Characterization, and Cell Viability Evaluation of Long-Circulating and pH-Sensitive Liposomes Containing Ursolic Acid
【24h】

Preparation, Physicochemical Characterization, and Cell Viability Evaluation of Long-Circulating and pH-Sensitive Liposomes Containing Ursolic Acid

机译:含熊果酸的长循环且对pH敏感的脂质体的制备,理化性质和细胞活力评估

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Cancer is one of the leading causes of death worldwide. Although several drugs are used clinically, some tumors either do not respond or are resistant to the existing pharmacotherapy, thus justifying the search for new drugs. Ursolic acid (UA) is a triterpene found in different plant species that has been shown to possess significant antitumor activity. However, UA presents a low solubility in aqueous medium, which presents a barrier to its biological applications. In this context, the use of liposomes presents a promising strategy to deliver UA and allow for its intravenous administration. In this work, long-circulating and pH-sensitive liposomes containing UA (SpHL-UA) were developed, and their chemical and physicochemical properties were evaluated. SpHL-UA presented adequate properties, including a mean diameter of 191.1 ± 6.4 nm, a zeta potential of 1.2 ± 1.4 mV, and a UA entrapment of 0.77 ± 0.01 mg/mL. Moreover, this formulation showed a good stabiEty after having been stored for 2 months at 4°C. The viability studies on breast (MDA-MB-231) and prostate (LNCaP) cancer cell lines demonstrated that SpHL-UA treatment significantly inhibited cancer cell proliferation. Therefore, the results of the present work suggest the applicability of SpHL-UA as a new and promising anticancer formulation.
机译:癌症是全球主要的死亡原因之一。尽管临床上使用了几种药物,但某些肿瘤对现有药物治疗无效或耐药,因此寻找新药是合理的。熊果酸(UA)是一种三萜烯,存在于不同的植物种中,已显示具有显着的抗肿瘤活性。但是,UA在水性介质中的溶解度较低,这对其生物学应用构成了障碍。在这种情况下,脂质体的使用提出了一种有希望的策略来递送UA并允许其静脉内施用。在这项工作中,开发了含有UA(SpHL-UA)的长循环且对pH敏感的脂质体,并对其化学和物理化学性质进行了评估。 SpHL-UA具有足够的特性,包括平均直径191.1±6.4 nm,ζ电位1.2±1.4 mV和UA截留0.77±0.01 mg / mL。此外,该制剂在4℃下保存2个月后显示出良好的稳定性。对乳腺癌(MDA-MB-231)和前列腺癌(LNCaP)细胞系的生存能力研究表明,SpHL-UA治疗显着抑制了癌细胞的增殖。因此,本工作的结果表明SpHL-UA作为一种新的和有希望的抗癌制剂的适用性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号